Adeno-associated virus-mediated bone morphogenetic protein-7 gene transfer induces C2C12 cell differentiation into osteoblast lineage cells

Acta Pharmacologica Sinica

Volumn 26, Issue 8, 2005, Pages 963-968

  Yang, Min ^a   Ma, Qing Jun ^a   Dang, Geng Ting ^a   Ma, Kang Tao ^b   Chen, Ping ^b   Zhou, Chun Yan ^b  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Adeno associated virus; Bone morphogenetic protein 7; C2C12; Gene therapy

Indexed keywords

ALKALINE PHOSPHATASE; HELICASE; MESSENGER RNA; MYOD PROTEIN; OSTEOCALCIN; PARVOVIRUS VECTOR; PROTEIN CAP; RECOMBINANT OSTEOGENIC PROTEIN 1; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ARTICLE; CELL CLONE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CELL LYSATE; CELL STRAIN; CELL STRAIN BHK 21; CELL STRAIN C2C12; CONTROLLED STUDY; CULTURE MEDIUM; DNA PACKAGING; ENZYME ACTIVITY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IN VITRO STUDY; MULTIPLICITY OF INFECTION; NONHUMAN; OSTEOBLAST; PROTEIN SECRETION; PROTEIN SYNTHESIS; RECOMBINANT ADENO ASSOCIATED VIRUS; RECOMBINANT HERPES SIMPLEX VIRUS 1; RECOMBINANT PLASMID; RECOMBINANT PLASMID SNAV; VIRUS ASSEMBLY; VIRUS GENE; VIRUS GENOME; VIRUS INFECTION; VIRUS PURIFICATION; VIRUS RECOMBINANT;

ALKALINE PHOSPHATASE; ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DEPENDOVIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC VECTORS; HUMANS; MYOBLASTS; MYOD PROTEIN; OSTEOBLASTS; OSTEOCALCIN; PLURIPOTENT STEM CELLS; RNA, MESSENGER; TIME FACTORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 23844511137     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2005.00159.x     Document Type: Article

References (28)

1. Hannallah D, Peterson B, Lieberman JR, Fu FH, Huard J. Gene therapy in orthopaedic surgery. J Bone Joint Surg Am 2002; 84A: 1046-61.
2. Monahan PE, Samulski RJ. AAV vectors: is clinical success on the horizon? Gene Ther 2000; 7: 24-30.
3. Luk KD, Chen Y, Cheung KM, Kung HF, Lu WW, Leong JC. Adeno-associated virus-mediated bone morphogenetic protein-4 gene therapy for in vivo bone formation. Biochem Biophys Res Commun 2003; 308: 636-45.
4. Chen Y, Luk KD, Cheung KM, Xu R, Lin MC, Lu WW, et al. Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors. Gene Ther 2003; 10: 1345-53.
5. Gafni Y, Pelled G, Zilberman Y, Turgeman G, Apparailly F, Yotvat H, et al. Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system. Mol Ther 2004; 9: 587-95.
6. Yeh LC, Tsai AD, Lee JC. Osteogenic protein-1 (OP-1, BMP-7) induces osteoblastic cell differentiation of the pluripotent mesenchymal cell line C2C12. J Cell Biochem 2002; 87: 292-304.
7. Okubo Y, Bessho K, Fujimura K, Iizuka T, Miyatake S. Expression of bone morphogenetic protein-2 via adenoviral vector in C2C12 myoblasts induces differentiation into the osteoblast lineage. Biochem Biophys Res Commun 1999; 262: 739-43.
8. Kim YJ, Lee MH, Wozney JM, Cho JY, Ryoo HM. Bone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2. J Biol Chem 2004; 279: 50773-80.
9. Wu ZJ, Wu XB, Hou YD. Construction of a series of adeno-associated virus vectors and their expression of β-galactosidase gene. Chin J Virol 2000; 16: 1-6.
10. Wu ZJ, Wu XB, Hou YD. Generation of a recombinant herpes simplex virus which can provide packaging function for recombinant adeno-associated virus. Chin Sci Bull 1999; 44: 715-9.
11. Wu XB, Dong XY, Wu ZJ, Cao H, Niu DB, Qu JG, et al. A novel method for purification of recombinant adeno-associated virus vectors on a large scale. Chin Sci Bull 2000; 45: 2071-5.
12. Ponnazhagan S, Yoder MC, Srivastava A. Adeno-associated virus type 2-mediated transduction of murine hematopoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo. J Virol 1997; 71: 3098-104.
13. Bonnelye E, Merdad L, Kung V, Aubin JE. The orphan nuclear estrogen receptor-related receptor α (ERRα) is expressed throughout osteoblast differentiation and regulates bone formation in vitro. J Cell Biol 2001; 153: 971-84.
14. Song CL, Guo ZQ, Ma QJ, Chen ZQ, Liu ZJ, Jia HT, et al. Simvastatin induces osteoblastic differentiation and inhibits adipocytic differentiation in mouse bone marrow stromal cells. Biochem Biophys Res Commun 2003; 308: 458-62.
15. Xiao ZS, Liu SG, Hinson TK, Quarles LD. Characterization of the upstream mouse Cbfa1/Runx2 promoter. J Cell Biochem 2001; 82: 647-59.
16. Li R, Wozney J. Delivering on the promise of bone morphogenetic proteins. Trends Biotechnol 2001; 19: 255-65.
17. Krebsbach PH, Gu K, Franceschi RT, Rutherford RB. Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo. Hum Gene Ther 2000; 11: 1201-10.
18. Franceschi RT, Wang D, Krebsbach PH, Rutherford RB. Gene therapy for bone formation: in vitro and in vivo osteogenic activity of an adenovirus expressing BMP7. J Cell Biochem 2000; 78: 476-86.
19. Breitbart AS, Grande DA, Mason JM, Barcia M, James T, Grant RT. Gene-enhanced tissue engineering: applications for bone healing using cultured periosteal cells transduced retrovirally with the BMP-7 gene. Ann Plast Surg 1999; 42: 488-95.
20. Mason JM, Grande DA, Barcia M, Grant R, Pergolizzi RG, Breitbart AS. Expression of human bone morphogenic protein 7 in primary rabbit periosteal cells: potential utility in gene therapy for osteochondrial repair. Gene Ther 1998; 5: 1098-104.
21. Schwarz EM. The adeno-associated virus vector for orthopaedic gene therapy. Clin Orthop 2000; 379 Suppl: S31-9.
22. Fux C, Langer D, Fussenegger M. Dual-regulated myoD- and msx1-based interventions in C2C12-derived cells enable precise myogenic/osteogenic/ adipogenic lineage control. J Gene Med 2004; 6: 1159-69.
23. Fux C, Mitta B, Kramer BP, Fussenegger M. Dual-regulated expression of C/EBP-α and BMP-2 enables differential differentiation of C2C12 cells into adipocytes and osteoblasts. Nucleic Acids Res 2004; 32: e1.
24. Tou L, Quibria N, Alexander JM. Transcriptional regulation of the human Runx2/Cbfa1 gene promoter by bone morphogenetic protein-7. Mol Cell Endocrinol 2003; 205: 121-9.
25. Zheng H, Guo Z, Ma Q, Jia H, Dang G. Cbfa1/osf2 transduced bone marrow stromal cells facilitate bone formation in vitro and in vivo. Calcif Tissue Int 2004; 74: 194-203.
26. Kay MA, Manno CS, Ragni MV, Larson PJ, Couto LB, McClelland A, et al. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat Genet 2000; 24: 257-61.
27. Song S, Morgan M, Ellis T, Poirier A, Chesnut K, Wang J, et al. Sustained secretion of human α-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc Natl Acad Sci USA 1998; 95: 14384-8.
28. Aubert D, Pichard V, Durand S, Moullier P, Ferry N. Cytotoxic immune response after retroviral-mediated hepatic gene transfer in rat does not preclude expression from adeno-associated virus 1 transduced muscles. Hum Gene Ther 2003; 14: 473-81.